Life science executives: We can feel the lack of traveling salespeople

Novo Nordisk and Coloplast have both experienced the necessity of salespeople pitching products in person, whereas Teva's Kåre Schultz highlights differences in the markets.
Photo: Stine Bidstrup/ERH
Photo: Stine Bidstrup/ERH
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

Although virtual meetings have become more widespread, also when selling medicine, Danish pharmaceutical company Novo Nordisk's experience with launching diabetes tablet Rybelsus has shown that they are not sufficient, according to Danish newspaper Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading